Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Maze Therapeutics, Inc. (MAZE)

30.37 -1.11 (-3.53%)
At close: November 2 at 4:00:01 PM EST
30.37 0.00 (0.00%)
After hours: November 2 at 4:33:55 PM EST
Trade MAZE on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
20,000
0
167,500
0
0
Operating Expense
165,612
142,899
109,914
98,551
111,026
Operating Income
-145,612
-142,899
57,586
-98,551
-111,026
Net Non Operating Interest Income Expense
12,022
11,779
4,654
1,966
2,028
Other Income Expense
--
--
-8,837
-3,830
-5,942
Pretax Income
-133,590
-131,120
53,403
-100,415
-114,940
Tax Provision
--
0
1,172
0
--
Net Income Common Stockholders
-133,590
-131,120
3,405
-100,415
-114,940
Diluted NI Available to Com Stockholders
-133,590
-131,120
3,405
-100,415
-114,940
Basic EPS
-2.44
-3.05
0.08
-2.87
-3.29
Diluted EPS
-2.44
-3.05
0.08
-2.87
-3.29
Basic Average Shares
53,078.94
42,976.02
43,776.98
34,970.94
34,970.94
Diluted Average Shares
53,078.94
42,976.02
43,776.98
35,400.79
35,400.79
Total Operating Income as Reported
-145,612
-142,899
57,586
-98,551
-111,026
Total Expenses
165,612
142,899
109,914
98,551
111,026
Net Income from Continuing & Discontinued Operation
-133,590
-131,120
52,231
-100,415
-114,940
Normalized Income
-133,590
-131,120
52,231
-100,415
-112,540
Interest Income
13,819
11,779
4,654
1,966
2,028
Net Interest Income
12,022
11,779
4,654
1,966
2,028
EBIT
-143,572
-142,899
57,586
-98,551
-111,026
EBITDA
-141,667
-140,496
60,883
-94,462
-107,206
Reconciled Depreciation
1,905
2,403
3,297
4,089
3,820
Net Income from Continuing Operation Net Minority Interest
-133,590
-131,120
52,231
-100,415
-114,940
Total Unusual Items Excluding Goodwill
--
--
--
0
-2,400
Total Unusual Items
--
--
--
0
-2,400
Normalized EBITDA
-141,667
-140,496
60,883
-94,462
-104,806
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 1/31/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: